-
Characterization of cortico-meningeal translocator protein expression in multiple sclerosis. Brain. 2024 Jul 05; 147(7):2566-2578.
Herranz E, Treaba CA, Barletta VT, Mehndiratta A, Ouellette R, Sloane JA, Ionete C, Babu S, Mastantuono M, Magon S, Loggia ML, Makary MM, Hooker JM, Catana C, Kinkel RP, Nicholas R, Klawiter EC, Magliozzi R, Mainero C. PMID: 38289855; PMCID: PMC11224595.
View in:
PubMed Mentions:
1 Fields:
Translation:
Humans
-
Analysis of Evusheld safety and efficacy in multiple sclerosis patients. Mult Scler Relat Disord. 2024 Aug; 88:105733.
Liu EN, Real M, Yang JH, Fair A, Whitmire N, Perez A, Wilder C, Rosengren S, Kinkel RP, Graves JS. PMID: 38901372.
View in:
PubMed Mentions: Fields:
Translation:
Humans
-
Frequency, characteristics, predictors and treatment of relapsing myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD). Mult Scler Relat Disord. 2024 Jul; 87:105672.
Rempe T, Rodriguez E, Elfasi A, Alkabie S, Perero MM, Castrodad-Molina R, Cuascut FX, Hutton GJ, Kinkel R, Graves J. PMID: 38749350.
View in:
PubMed Mentions: Fields:
Translation:
Humans
-
Senescence marker p16INK4a expression in patients with multiple sclerosis. Mult Scler Relat Disord. 2024 Apr; 84:105498.
Yang JH, Miner AE, Fair A, Kinkel R, Graves JS. PMID: 38359693.
View in:
PubMed Mentions:
1 Fields:
Translation:
HumansCells
-
Ocrelizumab B-cell repopulation-guided extended interval dosing versus standard dosing - similar clinical efficacy with decreased immunoglobulin M deficiency rates. Mult Scler Relat Disord. 2023 Nov; 79:105028.
Rempe T, Elfasi A, Rodriguez E, Vasquez M, Graves J, Kinkel R. PMID: 37813071.
View in:
PubMed Mentions:
1 Fields:
Translation:
Humans
-
The NHANES Biological Age Index demonstrates accelerated aging in MS patients. Mult Scler Relat Disord. 2023 Sep; 77:104859.
Miner AE, Yang JH, Kinkel RP, Graves JS. PMID: 37473592.
View in:
PubMed Mentions: Fields:
Translation:
Humans
-
Cortical and phase rim lesions on 7 T MRI as markers of multiple sclerosis disease progression. Brain Commun. 2021; 3(3):fcab134.
Treaba CA, Conti A, Klawiter EC, Barletta VT, Herranz E, Mehndiratta A, Russo AW, Sloane JA, Kinkel RP, Toschi N, Mainero C. PMID: 34704024; PMCID: PMC8361394.
View in:
PubMed Mentions:
14
-
Quantification of smooth pursuit dysfunction in multiple sclerosis. Mult Scler Relat Disord. 2021 Sep; 54:103073.
Rempe T, Dastgheyb N, Miner A, Palomino M, Kinkel R, Liston D, Graves JS. PMID: 34214878.
View in:
PubMed Mentions:
3 Fields:
Translation:
Humans
-
The relevance of multiple sclerosis cortical lesions on cortical thinning and their clinical impact as assessed by 7.0-T MRI. J Neurol. 2021 Jul; 268(7):2473-2481.
Treaba CA, Herranz E, Barletta VT, Mehndiratta A, Ouellette R, Sloane JA, Klawiter EC, Kinkel RP, Mainero C. PMID: 33523256.
View in:
PubMed Mentions:
9 Fields:
Translation:
Humans
-
Association of Serum Neurofilament Light Levels With Long-term Brain Atrophy in Patients With a First Multiple Sclerosis Episode. JAMA Netw Open. 2020 11 02; 3(11):e2016278.
Plavina T, Singh CM, Sangurdekar D, de Moor C, Engle B, Gafson A, Goyal J, Fisher E, Szak S, Kinkel RP, Sandrock AW, Su R, Kieseier BC, Rudick RA. PMID: 33151313; PMCID: PMC7645699.
View in:
PubMed Mentions:
12 Fields:
Translation:
Humans
-
MOG-IgG1 and co-existence of neuronal autoantibodies. Mult Scler. 2021 07; 27(8):1175-1186.
Kunchok A, Flanagan EP, Krecke KN, Chen JJ, Caceres JA, Dominick J, Ferguson I, Kinkel R, Probasco JC, Ruvalcaba M, Santoro JD, Sieloff K, Timothy J, Weinshenker BG, McKeon A, Pittock SJ. PMID: 32907470; PMCID: PMC8454216.
View in:
PubMed Mentions:
15 Fields:
Translation:
Humans
-
Characterization of thalamic lesions and their correlates in multiple sclerosis by ultra-high-field MRI. Mult Scler. 2021 04; 27(5):674-683.
Mehndiratta A, Treaba CA, Barletta V, Herranz E, Ouellette R, Sloane JA, Klawiter EC, Kinkel RP, Mainero C. PMID: 32584159; PMCID: PMC7759586.
View in:
PubMed Mentions:
9 Fields:
Translation:
Humans
-
Outcomes and Cost-Effectiveness of Autologous Hematopoietic Cell Transplant for Multiple Sclerosis. Curr Treat Options Neurol. 2019 Oct 17; 21(10):53.
Dunn-Pirio AM, Heyman BM, Kaufman DS, Kinkel RP. PMID: 31624926.
View in:
PubMed Mentions:
4
-
Longitudinal Characterization of Cortical Lesion Development and Evolution in Multiple Sclerosis with 7.0-T MRI. Radiology. 2019 06; 291(3):740-749.
Treaba CA, Granberg TE, Sormani MP, Herranz E, Ouellette RA, Louapre C, Sloane JA, Kinkel RP, Mainero C. PMID: 30964421; PMCID: PMC6543899.
View in:
PubMed Mentions:
35 Fields:
Translation:
Humans
-
Guided Imagery Improves Mood, Fatigue, and Quality of Life in Individuals With Multiple Sclerosis: An Exploratory Efficacy Trial of Healing Light Guided Imagery. J Evid Based Integr Med. 2018 Jan-Dec; 23:2515690X17748744.
Case LK, Jackson P, Kinkel R, Mills PJ. PMID: 29405761; PMCID: PMC5871039.
View in:
PubMed Mentions:
8 Fields:
Translation:
HumansCTClinical Trials
-
Heterogeneous pathological processes account for thalamic degeneration in multiple sclerosis: Insights from 7 T imaging. Mult Scler. 2018 10; 24(11):1433-1444.
Louapre C, Govindarajan ST, Giannì C, Madigan N, Sloane JA, Treaba CA, Herranz E, Kinkel RP, Mainero C. PMID: 28803512.
View in:
PubMed Mentions:
24 Fields:
Translation:
Humans
-
The association between intra- and juxta-cortical pathology and cognitive impairment in multiple sclerosis by quantitative T2* mapping at 7 T MRI. Neuroimage Clin. 2016; 12:879-886.
Louapre C, Govindarajan ST, Giannì C, Madigan N, Nielsen AS, Sloane JA, Kinkel RP, Mainero C. PMID: 27872810; PMCID: PMC5107649.
View in:
PubMed Mentions:
16 Fields:
Translation:
Humans
-
Neuroinflammatory component of gray matter pathology in multiple sclerosis. Ann Neurol. 2016 Nov; 80(5):776-790.
Herranz E, Giannì C, Louapre C, Treaba CA, Govindarajan ST, Ouellette R, Loggia ML, Sloane JA, Madigan N, Izquierdo-Garcia D, Ward N, Mangeat G, Granberg T, Klawiter EC, Catana C, Hooker JM, Taylor N, Ionete C, Kinkel RP, Mainero C. PMID: 27686563; PMCID: PMC5115951.
View in:
PubMed Mentions:
88 Fields:
Translation:
Humans
-
Beyond focal cortical lesions in MS: An in vivo quantitative and spatial imaging study at 7T. Neurology. 2015 Nov 10; 85(19):1702-9.
Louapre C, Govindarajan ST, Giannì C, Langkammer C, Sloane JA, Kinkel RP, Mainero C. PMID: 26468411; PMCID: PMC4653110.
View in:
PubMed Mentions:
21 Fields:
Translation:
Humans
-
Is the Relationship between Cortical and White Matter Pathologic Changes in Multiple Sclerosis Spatially Specific? A Multimodal 7-T and 3-T MR Imaging Study with Surface and Tract-based Analysis. Radiology. 2016 Feb; 278(2):524-35.
Louapre C, Govindarajan ST, Giannì C, Cohen-Adad J, Gregory MD, Nielsen AS, Madigan N, Sloane JA, Kinkel RP, Mainero C. PMID: 26334679; PMCID: PMC4734161.
View in:
PubMed Mentions:
8 Fields:
Translation:
HumansCells
-
No Evidence of Disease Activity in Multiple Sclerosis. JAMA Neurol. 2015 Jul; 72(7):835-6.
Sloane JA, Mainero C, Kinkel RP. PMID: 26167901.
View in:
PubMed Mentions:
3 Fields:
Translation:
Humans
-
A gradient in cortical pathology in multiple sclerosis by in vivo quantitative 7 T imaging. Brain. 2015 Apr; 138(Pt 4):932-45.
Mainero C, Louapre C, Govindarajan ST, Giannì C, Nielsen AS, Cohen-Adad J, Sloane J, Kinkel RP. PMID: 25681411; PMCID: PMC4677339.
View in:
PubMed Mentions:
68 Fields:
Translation:
Humans
-
Disease-related determinants of quality of life 10 years after clinically isolated syndrome. Int J MS Care. 2015 Jan-Feb; 17(1):26-34.
Kinkel RP, Laforet G, You X. PMID: 25741224; PMCID: PMC4338640.
View in:
PubMed Mentions:
3
-
Quantitative oxygen extraction fraction from 7-Tesla MRI phase: reproducibility and application in multiple sclerosis. J Cereb Blood Flow Metab. 2015 Jan; 35(1):131-9.
Fan AP, Govindarajan ST, Kinkel RP, Madigan NK, Nielsen AS, Benner T, Tinelli E, Rosen BR, Adalsteinsson E, Mainero C. PMID: 25352043; PMCID: PMC4294406.
View in:
PubMed Mentions:
27 Fields:
Translation:
Humans
-
Early MRI activity predicts treatment nonresponse with intramuscular interferon beta-1a in clinically isolated syndrome. Mult Scler Relat Disord. 2014 Nov; 3(6):712-9.
Kinkel RP, Simon JH, O'Connor P, Hyde R, Pace A. PMID: 25891550.
View in:
PubMed Mentions:
4 Fields:
Translation:
Humans
-
JC virus reactivation during prolonged natalizumab monotherapy for multiple sclerosis. Ann Neurol. 2014 Jun; 75(6):925-34.
Chalkias S, Dang X, Bord E, Stein MC, Kinkel RP, Sloane JA, Donnelly M, Ionete C, Houtchens MK, Buckle GJ, Batson S, Koralnik IJ. PMID: 24687904; PMCID: PMC4425205.
View in:
PubMed Mentions:
28 Fields:
Translation:
HumansCells
-
Contribution of cortical lesion subtypes at 7T MRI to physical and cognitive performance in MS. Neurology. 2013 Aug 13; 81(7):641-9.
Nielsen AS, Kinkel RP, Madigan N, Tinelli E, Benner T, Mainero C. PMID: 23864311; PMCID: PMC3775688.
View in:
PubMed Mentions:
58 Fields:
Translation:
Humans
-
Focal cortical lesion detection in multiple sclerosis: 3 Tesla DIR versus 7 Tesla FLASH-T2. J Magn Reson Imaging. 2012 Mar; 35(3):537-42.
Nielsen AS, Kinkel RP, Tinelli E, Benner T, Cohen-Adad J, Mainero C. PMID: 22045554; PMCID: PMC4198329.
View in:
PubMed Mentions:
46 Fields:
Translation:
HumansCells
-
Association between immediate initiation of intramuscular interferon beta-1a at the time of a clinically isolated syndrome and long-term outcomes: a 10-year follow-up of the Controlled High-Risk Avonex Multiple Sclerosis Prevention Study in Ongoing Neurological Surveillance. Arch Neurol. 2012 Feb; 69(2):183-90.
Kinkel RP, Dontchev M, Kollman C, Skaramagas TT, O'Connor PW, Simon JH, Controlled High-Risk Avonex Multiple Sclerosis Prevention Study in Ongoing Neurological Surveillance. PMID: 21987393.
View in:
PubMed Mentions:
32 Fields:
Translation:
HumansPHPublic Health
-
Maximally tolerated versus minimally effective dose: the case of rituximab in multiple sclerosis. Mult Scler. 2012 Mar; 18(3):377-8.
Nielsen AS, Miravalle A, Langer-Gould A, Cooper J, Edwards KR, Kinkel RP. PMID: 21828201.
View in:
PubMed Mentions:
11 Fields:
Translation:
HumansCellsCTClinical Trials
-
Internet portal use in an academic multiple sclerosis center. J Am Med Inform Assoc. 2012 Jan-Feb; 19(1):128-33.
Nielsen AS, Halamka JD, Kinkel RP. PMID: 21571744; PMCID: PMC3240754.
View in:
PubMed Mentions:
26 Fields:
Translation:
Humans
-
Experiences acquiring and using mobility aids among working-age persons with multiple sclerosis living in communities in the United States. Am J Phys Med Rehabil. 2010 Dec; 89(12):1010-23.
Iezzoni LI, Rao SR, Kinkel RP. PMID: 20881588.
View in:
PubMed Mentions:
3 Fields:
Translation:
Humans
-
Immune reconstitution inflammatory syndrome in patients with multiple sclerosis following cessation of natalizumab therapy. Arch Neurol. 2011 Feb; 68(2):186-91.
Miravalle A, Jensen R, Kinkel RP. PMID: 20937940.
View in:
PubMed Mentions:
52 Fields:
Translation:
HumansPHPublic Health
-
Asymptomatic reactivation of JC virus in patients treated with natalizumab. N Engl J Med. 2009 Sep 10; 361(11):1067-74.
Chen Y, Bord E, Tompkins T, Miller J, Tan CS, Kinkel RP, Stein MC, Viscidi RP, Ngo LH, Koralnik IJ. PMID: 19741227; PMCID: PMC3077718.
View in:
PubMed Mentions:
93 Fields:
Translation:
HumansCellsCTClinical Trials
-
Patterns of mobility aid use among working-age persons with multiple sclerosis living in the community in the United States. Disabil Health J. 2009 Apr; 2(2):67-76.
Iezzoni LI, Rao SR, Kinkel RP. PMID: 21122745.
View in:
PubMed Mentions:
5 Fields:
Translation:
Humans
-
Health-related quality of life assessment in multiple sclerosis. Rev Neurol Dis. 2008; 5(2):56-64.
Miller DM, Kinkel RP. PMID: 18660737.
View in:
PubMed Mentions:
5 Fields:
Translation:
Humans
-
Acute paraplegia with vanishing white matter lesions. Rev Neurol Dis. 2008; 5(3):159-60; discussion 164-6.
Jensen RM, Kinkel RP. PMID: 18838956.
View in:
PubMed Mentions: Fields:
Translation:
Humans
-
Interferon-beta1a: a once-weekly immunomodulatory treatment for patients with multiple sclerosis. Expert Rev Clin Immunol. 2006 Sep; 2(5):691-704.
Kinkel RP. PMID: 20477625.
View in:
PubMed Mentions:
1 Fields:
-
IM interferon beta-1a delays definite multiple sclerosis 5 years after a first demyelinating event. Neurology. 2006 Mar 14; 66(5):678-84.
Kinkel RP, Kollman C, O'Connor P, Murray TJ, Simon J, Arnold D, Bakshi R, Weinstock-Gutman B, Brod S, Cooper J, Duquette P, Eggenberger E, Felton W, Fox R, Freedman M, Galetta S, Goodman A, Guarnaccia J, Hashimoto S, Horowitz S, Javerbaum J, Kasper L, Kaufman M, Kerson L, Mass M, Rammohan K, Reiss M, Rolak L, Rose J, Scott T, Selhorst J, Shin R, Smith C, Stuart W, Thurston S, Wall M, CHAMPIONS Study Group. PMID: 16436649.
View in:
PubMed Mentions:
66 Fields:
Translation:
Humans
-
Interferon beta-1a for early multiple sclerosis: CHAMPS trial subgroup analyses. Ann Neurol. 2002 Apr; 51(4):481-90.
Beck RW, Chandler DL, Cole SR, Simon JH, Jacobs LD, Kinkel RP, Selhorst JB, Rose JW, Cooper JA, Rice G, Murray TJ, Sandrock AW. PMID: 11921054.
View in:
PubMed Mentions:
29 Fields:
Translation:
HumansCTClinical Trials